All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
ALZ-NET Case Study Series
August 29 @ 3:00 pm - 4:00 pm
Join us on August 29, 2024 from 9-10am CT for the third episode of Series 1 of the ALZ-NET International Case Study Series, which will explore eligibility of patients for treatment.
Three cases will be discussed in Episode 3.
Presenter #1:
Eligibility for MAB: 70 year old with language variant AD. Borderline MMSE, but fully intact functionally. Apolipoprotein e4e4 genotype.
Eligibility for Brexpiprazole: 72 yo with gradual onset memory loss. MoCA 19/30, higher level functional changes, and verbal agitation.
Presenter #2:
Eligibility for MAB: 75 year old with mild cognitive impairment due to AD. CSF biomarkers abnormal including abeta 42/40. MRI showed ischemic microangiopathy. Apolipoprotein e4 non carrier. On a liquid for atrial fibrillation. CDR sum of boxes 0.5. CDR global 0.5. FAQ 1. MoCA 27/30.
Presenters: David Weisman, Margarita Reyes
—–
The views and opinions expressed in this webinar are solely those of the guests and do not necessarily reflect those of the Alzheimer’s Association. The Alzheimer’s Association does not endorse any external product or service. This webinar is for informational purposes and is not intended to provide medical advice.